Inactive Instrument

Coland Holdings Limited

4144

KYG2379A1094

Coland Holdings Limited Proposes Dividend

February 25, 2019 at 09:48 am

Coland Holdings Limited proposed dividend of TWD 0.525 per share.

Latest news about Coland Holdings Limited

Coland Holdings Limited Announces the Financial Supervisory Commission Approval of the Termination of the Its Public Company Status Since October 30, 2020	13/10/20	CI
Coland Holdings Limited Reports Impairment of Assets for the Second Quarter of 2020	13/08/20	CI
Coland Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/08/20	CI
Oceanic World Sub Corp entered into Letter of Intent to acquire Coland Holdings Limited for TWD 2 billion.	26/07/20	CI
Coland Holdings Limited Announces Cash Dividend	22/07/20	CI
Golden Hexagon Investments Limited made a tender offer to acquire an additional 15% stake in Coland Holdings Limited for approximately TWD 310 million.	10/06/20	CI
Coland Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	11/05/20	CI
Coland Holdings Limited Announces the Appointment of Tsao Johua as Company's New Head of Company Secretary	18/03/20	CI
Coland Holdings Limited Proposes Dividend Distribution	18/03/20	CI
Coland Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	17/03/20	CI
Coland Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	13/11/19	CI
Coland Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	13/08/19	CI
Coland Holdings Limited Approves Distribution for 2018	30/05/19	CI
Coland Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2019	13/05/19	CI
Coland Holdings Limited Proposes Dividend	25/02/19	CI
Coland Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2018	24/02/19	CI
Coland Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Reports Impairment Charges for the Third Quarter of 2018	13/11/18	CI
Coland Holdings Limited announced that it expects to receive TWD 405 million in funding	19/08/18	CI
Coland Holdings Limited Approves Distribution for 2017	15/06/18	CI
Coland Holdings Seeks Acquisitions	27/04/18	CI
Coland Holdings Limited announced that it expects to receive TWD 250 million in funding	26/04/18	CI
An unknown buyer cancelled the acquisition of Revlis Biotech Co., Ltd. from Coland Holdings Limited.	23/03/18	CI
An unknown buyer cancelled the acquisition of CDIB Healthcare Fund Ltd. from Coland Holdings Limited.	23/03/18	CI
The transaction has been cancelled as per closing tool guideline.	23/03/18	CI
Coland Holdings Limited Reports Earnings Results for the Month of February 2018, Fourth Quarter of 2017 and Full Year 2017	23/03/18	CI

Coland Holdings Limited is a Taiwan-based company principally engaged in the development and distribution of pharmaceuticals. The Company provides products for the treatment of hepatitis, respiratory system diseases, urinary systems, cardiovascular and nervous system diseases. The Company also offers medical equipment, spinal instrumentations and antibiotics. Its products include Adefovir Dipivoxil Tablets, Mycophenolate Mofetil Dispersible Tablets, Tiotropium Bromide Powder For Inhalation, Amoxicillin Sodium and Clavulanate Potassium for Injection and Lamivudine Tablets. The Company operates its businesses primarily in Mainland China.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+19.22%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals